1-3 of 3
Zoulika Zak
Close
Sort by
Journal Articles

Targeting N-Myristoylation for Adult Acute Myeloid Leukemia Therapy

Jay Gamma, Erwan Beauchamp, Qiang Liu, Aishwarya Iyer, Megan Yap, Zoulika Zak, Cassidy Ekstrom, Krista Vincent, Joseph Brandwein, Jean C.Y. Wang, Naveen Pemmaraju, Gautam Borthakur, John R. Mackey, Luc G. Berthiaume
Journal: Blood
Blood (2022) 140 (Supplement 1): 3088–3089.
https://doi.org/10.1182/blood-2022-170544
Published: 2022
Journal Articles

Validation of NMT1 and NMT2 As Novel Drug Targets in Adult Acute Myeloid Leukemia: Rationale for N-Myristoyltransferase Inhibition with Pclx-001 for Clinical Trials

Jay Gamma, Aishwarya Iyer, Megan Yap, Zoulika Zak, Krista Vincent, Cassidy Ekstrom, Erwan Beauchamp, Lynne Postovit, John R. Mackey, Naveen Pemmaraju, Gautam Borthakur, Joseph Brandwein, Luc G. Berthiaume
Journal: Blood
Blood (2021) 138 (Supplement 1): 4344.
https://doi.org/10.1182/blood-2021-154000
Published: 2021
Journal Articles

N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker

Ryan J Stubbins, MDMSc, Zoulika Zak, Aishwarya Iyer, Megan Yap, Krista Vincent, Lynne M Postovit, MD, John R Mackey, MD, Artur J Szkotak, MD PhD, Lalit Saini, MD, Luc G Berthiaume, PhD, Joseph M. Brandwein, MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3914.
https://doi.org/10.1182/blood.V130.Suppl_1.3914.3914
Published: 2017